<DOC>
	<DOCNO>NCT01018225</DOCNO>
	<brief_summary>The purpose study evaluate efficacy darifenacin treatment moderate severe nocturia patient overactive bladder non-urologic cause nocturia .</brief_summary>
	<brief_title>Exploratory Study Evaluating Effects Darifenacin Nocturia , Sleep Daytime Wakefulness</brief_title>
	<detailed_description />
	<mesh_term>Nocturia</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Subject must age 2170 , inclusive . Subject mush give write , personally sign date informed consent . Subject must diagnose overactive bladder . Subject must nocturia frequency great equal 3 episode night . Subject must male nonpregnant , nonlactating female agree comply applicable contraceptive requirement . Subject understand able , nd likely fully comply study procedure restriction . Subject concurrent chronic acute illness unstable medical condition either treat untreated could confound result safety assessment , increase risk subject lead difficulty comply protocol . The subject know suspected allergy , hypersensitivity , medical contraindication darifenacin ( Enablex® ) ( component ) . The subject concomitant disease use anticholinergic drug contraindicate , e.g . urinary retention , bladder obstruction , gastric retention severe decrease gastrointestinal motility condition , uncontrolled narrowangle glaucoma , myasthenia gravis , severe hepatic impairment ( Child Pugh C ) , severe ulcerative colitis , toxic megacolon , patient risk condition . Subject take another drug consider significant anticholinergic activity . Use drug know effect cognition , alertness drowsiness , benzodiazepine , sedate antihistamine , opioids , sedative hypnotic drug . Subject moderate severe obstructive sleep apnea ( Apnea/Hypopnea Index ≥ 15 ) Subject medical condition OAB likely cause subject 's nocturia ( e.g. , primary sleep disorder , polydipsia , polyuria ) . Subject take another investigational drug take part clinical trial within last 30 day prior Screening . The female subject pregnant lactating . Subjects urine drug screen positive stimulant , barbiturate , hallucinogen , opiate , cocaine , cannabis , amphetamine</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>